Respiratory and nutritional support in amyotrophic lateral sclerosis

Current Treatment Options in Neurology

Volumn 16, Issue 2, 2014, Pages

  Goyal, Namita A ^a   Mozaffar, Tahseen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ALS; Amyotrophic lateral sclerosis; Diaphragmatic pacing; Enteral nutrition; Noninvasive ventilation; Nutritional support; Percutaneous endoscopic gastrostomy; Respiratory insufficiency; Respiratory support

Indexed keywords

ALTERNATIVE MEDICINE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; DIAPHRAGMATIC PACING STIMULATION; ENTERIC FEEDING; FORCED VITAL CAPACITY; HUMAN; HYPERCAPNIA; LUNG FUNCTION TEST; LUNG PRESSURE; MALNUTRITION; NONINVASIVE POSITIVE PRESSURE VENTILATION; NONINVASIVE VENTILATION; NOSE FEEDING; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT CARE; RESPIRATORY FAILURE; VITAMIN SUPPLEMENTATION;

EID: 84891404959     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-013-0270-5     Document Type: Article

References (85)

1. Rowland, Shneider N. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688-700.
2. Miller R, Mitchell J, Moore D. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;3:CD001447.
3. Miller R, Rosenberg J, Gelinas D, et al. Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311-23.
4. Miller R, Jackson C, Kasarskis E, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218-26.
5. Corcia P, Meininger V. Management of amyotrophic lateral sclerosis. Drugs. 2008;68(8):1037-48.
6. Chiò A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-23.
7. Bergofsky E. Respiratory failure in disorders of the thoracic cage. Am Rev Respir Dis. 1979;119(4):643-69.
8. De Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax. 1980;35(8):603-10.
9. Bach J. Amyotrophic lateral sclerosis: Prolongation of life by noninvasive respiratory AIDS. Chest. 2002;122(1):92-8.
10. Hadjikoutis S, Wiles C. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scand. 2001;103(4):207-13.
11. Mustfa N, Moxham J. Respiratory muscle assessment in motor neurone disease. QJM. 2001;94(9):497-502.
12. Bourke S, Tomlinson M, Williams T, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomised controlled trial. Lancet Neurol. 2006;5(2):140-7.
13. Pinto A, de Carvalho M, Evangelista T, et al. Nocturnal pulse oximetry: A new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(1):31-5.
14. Bourke S, Bullock R, Williams T, et al. Noninvasive ventilation in ALS: Indications and effect on quality of life. Neurology. 2003;61(2):171-7.
15. Carratù P, Spicuzza L, Cassano A, et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency. Orphanet J Rare Dis. 2009;4:10.
16. Kleopa K, Sherman M, Neal B, et al. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164(1):82-8.
17. McKim D, Road J, Avendano M, et al. Home mechanical ventilation: A Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18(4):197-215.
18. Melo J, Homma A, Iturriaga E, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: A multicenter survey and proposal of a pulmonary protocol. J Neurol Sci. 1999;169(1-2):114-7.
19. Czaplinski A, Yen A, Appel S. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77(3):390-2.
20. Hardiman O. Management of respiratory symptoms in ALS. J Neurol. 2011;258(3):359-65.
21. Varrato J, Siderowf A, Damiano P, et al. Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology. 2001;57(2):357-9.
22. Baumann F, Henderson R, Morrison S, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1-2):194-202.
23. Lechtzin N, Wiener C, Shade D, et al. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest. 2002;121(2):436-42.
24. Fitting J, Paillex R, Hirt L, et al. Sniff nasal pressure: A sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46(6):887-93.
25. Morgan R, McNally S, Alexander M, et al. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171(3):269-74.
26. Lyall R, Donaldson N, Polkey M, et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124(Pt 10):2000-13.
27. Stefanutti D, Benoist M, Scheinmann P, et al. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1507-11.
28. Jackson C, Rosenfeld J, Moore D, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191(1-2):75-8.
29. Rafiq M, Bradburn M, Proctor A, et al. Using transcutaneous carbon dioxide monitor (TOSCA 500) to detect respiratory failure in patients with amyotrophic lateral sclerosis: A validation study. Amyotroph Lateral Scler. 2012;13(6):528-32.
30. Chaudri M, Liu C, Hubbard R, et al. Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J. 2002;19(3):434-8.
31. Mustfa N, Walsh E, Bryant V, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211-7.
32. Andersen P, Borasio G, Dengler R, et al. Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points EALSC Working Group Amyotroph Lateral Scler. 2007;8(4):195-213.
33. Radunovic A, Annane D, Rafiq M, et al. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2013;3:CD004427.
34. Gruis K, Lechtzin N. Respiratory therapies for amyotrophic lateral sclerosis: A primer. Muscle Nerve. 2012;46(3):313-31.
35. Gruis K, Brown D, Schoennemann A, et al. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2005;32(6):808-11.
36. Olney R, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65(11):1774-7.
37. Jaye J, Chatwin M, Dayer M, et al. Autotitrating versus standard noninvasive ventilation: A randomised crossover trial. Eur Respir J. 2009;33(3):566-71.
38. Onders R, Carlin A, Elmo M, et al. Amyotrophic lateral sclerosis: The Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed. Am J Surg. 2009;197(3):386-90.
39. Moss A, Casey P, Stocking C, et al. Home ventilation for amyotrophic lateral sclerosis patients: Outcomes, costs, and patient, family, and physician attitudes. Neurology. 1993;43(2):438-43.
40. Borasio G, Gelinas D, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: A crosscultural perspective. J Neurol. 1998;245 Suppl 2:S7-12.
41. Vianello A, Arcaro G, Palmieri A, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care. 2011;26(3
42. Kaub-Wittemer D, Steinbüchel N, Wasner M, et al. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26(4):890-6.
43. Bach J, Bianchi C, Aufiero E. Oximetry and indications for tracheotomy for amyotrophic lateral sclerosis. Chest. 2004;126(5):1502-7.
44. Bradley W, Anderson F, Gowda N, et al. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):240-4.
45. Chiò A, Calvo A, Ghiglione P, et al. Tracheostomy in amyotrophic lateral sclerosis: A 10-year populationbased study in Italy. J Neurol Neurosurg Psychiatry. 2010;81(10):1141-3.
46. Lo Coco D, Marchese S, La Bella V, et al. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. Chest. 2007;132(1):64-9.
47. Hayashi H, Oppenheimer E. ALS patients on TPPV: Totally locked-in state, neurologic findings and ethical implications. Neurology. 2003;61(1):135-7.
48. Rabkin J, Albert S, Tider T, et al. Predictors and course of elective long-term mechanical ventilation: A prospective study of ALS patients. Amyotroph Lateral Scler. 2006;7(2):86-95.
49. Sancho J, Servera E, Díaz J, et al. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest. 2004;125(4):1400-5.
50. Arens R, Gozal D, Omlin K, et al. Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med. 1994;150(4):1154-7.
51. Warwick W, Hansen L. The long-term effect of highfrequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatr Pulmonol. 1991;11(3):265-71.
52. Chaisson K, Walsh S, Simmons Z, et al. A clinical pilot study: High frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2006;7(2):107-11.
53. Piquet MA. [Nutritional approach for patients with amyotrophic lateral sclerosis]. Rev Neurol (Paris). 2006;162(Spec No 2):4S177-4S187.
54. Traynor B, Codd M, Corr B, et al. Incidence and prevalence of ALS in Ireland, 1995-1997: A population-based study. Neurology. 1999;52(3):504-9.
55. Borasio G, Shaw P, Hardiman O, et al. Standards of palliative care for patients with amyotrophic lateral sclerosis: Results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(3):159-64.
56. Desport J, Preux P, Truong C, et al. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(2):91-6.
57. Desport J, Preux P, Truong T, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059-63.
58. Heffernan C, Jenkinson C, Holmes T, et al. Nutritional management in MND/ALS patients: An evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(2):72-83.
59. Kasarskis E, Neville H. Management of ALS: Nutritional care. Neurology. 1996;47(4 Suppl 2):S118-20.
60. Atsuta N, Watanabe H, Ito M, et al. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2009;276(1-2):163-9.
61. Mitsumoto H, Rabkin J. Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best". JAMA. 2007;298(2):207-16.
62. Park J, Kang S-W. Percutaneous radiologic gastrostomy in patients with amyotrophic lateral sclerosis on noninvasive ventilation. Arch Phys Med Rehabil. 2009;90(6):1026-9.
63. Mattson M, Cutler R, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med. 2007;9(1):17-20.
64. Dupuis L, Oudart H, René F, et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101(30):11159-64.
65. Hamadeh M, Rodriguez M, Kaczor J, et al. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Znsuperoxide dismutase mutant G93A mouse. Muscle Nerve. 2005;31(2):214-20.
66. Langmore S. Issues in the management of dysphagia. Folia Phoniatr Logop. 1999;51(4-5):220-30.
67. Perry A, Anderson K, Lean R, et al. Elevation of the soft palate in speech and swallowing in normal female participants and females with motor neuron disease: An innovative procedure for measuring palatal elevation. Int J Lang Commun Disord. 2002;37(2):197-214.
68. Cameron A, Rosenfeld J. Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders. Curr Opin Clin Nutr Metab Care. 2002;5(6):631-43.
69. Katzberg H, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2011;1:CD004030.
70. Allen J, Chen R, Ajroud-Driss S, et al. Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: A retrospective study of complications and outcome. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(4):308-14.
71. Desport J-C, Mabrouk T, Bouillet P, et al. Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(2):88-93.
72. McLoughlin R, Gibney R. Fluoroscopically guided percutaneous gastrostomy: Tube function and malfunction. Abdom Imaging. 1994;19(3):195-200.
73. Chiò A, Finocchiaro E, Meineri P, et al. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology. 1999;53(5):1123-5.
74. Desport J-C, Torny F, Lacoste M, et al. Hypermetabolism in ALS: Correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2(3-4):202-7.
75. Mazzini L, Corrà T, Zaccala M, et al. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242(10):695-8.
76. Mitsumoto H, Davidson M, Moore D, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(3):177-85.
77. Shaw A, Ampong M-A, Rio A, et al. Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: A retrospective review of 98 patients in a single centre. Amyotroph Lateral Scler. 2006;7(1):16-21.
78. Verschueren A, Monnier A, Attarian S, et al. Enteral and parenteral nutrition in the later stages of ALS: An observational study. Amyotroph Lateral Scler. 2009;10(1):42-6.
79. Rosenfeld J, Ellis A. Nutrition and dietary supplements in motor neuron disease. Phys Med Rehabil Clin N Am. 2008;19(3):573.
80. Körner S, Hendricks M, Kollewe K, et al. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84.
81. Groeneveld G, Veldink J, van der Tweel I, et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol. 2003;53(4):437-45.
82. Shefner J, Cudkowicz M, Schoenfeld D, et al. A clinical trial of creatine in ALS. Neurology. 2004;63(9):1656-61.
83. Desnuelle C, Dib M, Garrel C, et al. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(1):9-18.
84. Graf M, Ecker D, Horowski R, et al. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: Results of a placebo-controlled double-blind study. J Neural Transm. 2005;112(5):649-60.
85. Orrell R. Understanding the causes of amyotrophic lateral sclerosis. N Engl J Med. 2007;357(8):822-3.